HIV Archives

In the Lab Sharon Begley

CRISPR identifies genes that might be targeted to hobble HIV infection

Pharmalot Ed Silverman

Gilead asks FDA to expand exclusivity for a key HIV drug

In the Lab Shayla Love

Genetic fossil-hunters dig through HIV’s long history for clues to new treatments

In the Lab Andrew Joseph

A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests

Health Dylan Scott

In Trump’s America, towns in poor health don’t think he will save them

Heavyweights Rebecca Robbins

The drug pricing crusader at the center of one of the nastiest fights of the election season

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England

Health Lindzi Wessel

High rates of injection drug use increases gay teens’ HIV risk

First Opinion Peter Piot and Mitchell Warren

Prevention must be at the forefront to meet global HIV goals

Health Ike Swetlitz

HIV drugs protect against transmission, even in unprotected sex

Pharmalot Ed Silverman

Gilead’s new price hikes on HIV drugs anger AIDS activists

Business Rebecca Robbins

Gilead hikes price of HIV therapies, other drugs by up to 10 percent

In the Lab Eric Boodman

Inside a monkey lab, research gets fast-tracked in the ‘Zika room’

First Opinion Benjamin Mazer

HIV

Most Read

Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs

ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when

Pharmalittle: Pfizer to merge off-patent business with Mylan; conservatives try to sabotage Trump pricing plan

Pharmalittle: Glaxo is set to hire a new chairman; Gilead tries to bulk up with new deal

AIDS groups criticize Express Scripts for excluding several HIV medicines

Gilead will donate Truvada for HIV prevention, but reaction is mixed

Once-a-day pills for combating HIV are a better deal than some people think

Gilead’s HIV prevention pill can greatly reduce new infections in targeted rollouts

All Coverage

CRISPR identifies genes that might be targeted to hobble HIV infection

Gilead asks FDA to expand exclusivity for a key HIV drug

Genetic fossil-hunters dig through HIV’s long history for clues to new treatments

A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests

In Trump’s America, towns in poor health don’t think he will save them

The drug pricing crusader at the center of one of the nastiest fights of the election season

Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England

High rates of injection drug use increases gay teens’ HIV risk

Prevention must be at the forefront to meet global HIV goals

HIV drugs protect against transmission, even in unprotected sex

Gilead’s new price hikes on HIV drugs anger AIDS activists

Gilead hikes price of HIV therapies, other drugs by up to 10 percent

Inside a monkey lab, research gets fast-tracked in the ‘Zika room’

We are not viruses: Don’t limit gay men from donating blood

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day